Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Chimiothérapie
- Thérapies Ciblées
Extract
A randomized, multicentre, open-label, phase III study of lapatinib plus capecitabine versus trastuzumab plus capecitabine in patients with anthracycline- or taxane-exposed ErbB2-positive metastatic breast cancer.
Scientific Abstract
en cours d'intégration;